• 1. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Trifluoromethylbenzenes

Recent Advances in the Application of [2-fluoro-4-(trifluoromethyl)phenyl]hydrazine hydrochloride (CAS: 1030313-53-1) in Chemical Biology and Pharmaceutical Research

The compound [2-fluoro-4-(trifluoromethyl)phenyl]hydrazine hydrochloride (CAS: 1030313-53-1) has recently garnered significant attention in chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. This hydrazine derivative, characterized by its unique fluorine and trifluoromethyl substitutions, serves as a critical building block in the synthesis of biologically active molecules. Recent studies have highlighted its role in the development of novel therapeutic agents, particularly in the areas of oncology, infectious diseases, and central nervous system disorders.

One of the most notable applications of [2-fluoro-4-(trifluoromethyl)phenyl]hydrazine hydrochloride is its use as a key intermediate in the synthesis of small-molecule inhibitors targeting specific enzymes and receptors. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in the development of potent kinase inhibitors for cancer therapy. The researchers utilized this compound to introduce a fluorine-rich pharmacophore, which enhanced the binding affinity and selectivity of the inhibitors towards their target kinases. The study reported a significant improvement in the pharmacokinetic properties of the resulting compounds, attributed to the strategic incorporation of the trifluoromethyl group.

In addition to its role in oncology, [2-fluoro-4-(trifluoromethyl)phenyl]hydrazine hydrochloride has been employed in the design of antimicrobial agents. A recent publication in Bioorganic & Medicinal Chemistry Letters detailed its use in the synthesis of novel hydrazide derivatives with potent activity against drug-resistant bacterial strains. The researchers attributed the enhanced antibacterial efficacy to the electron-withdrawing effects of the fluorine and trifluoromethyl groups, which improved the compounds' ability to penetrate bacterial cell membranes and disrupt essential metabolic pathways.

Furthermore, the compound has shown promise in the field of neuropharmacology. A 2022 study in ACS Chemical Neuroscience explored its application in the development of modulators for neurotransmitter receptors. The study revealed that derivatives of [2-fluoro-4-(trifluoromethyl)phenyl]hydrazine hydrochloride exhibited high affinity for GABA_A receptors, suggesting potential applications in the treatment of anxiety and epilepsy. The researchers emphasized the importance of the fluorine substituents in optimizing the compounds' blood-brain barrier permeability and metabolic stability.

Despite its promising applications, challenges remain in the large-scale synthesis and purification of [2-fluoro-4-(trifluoromethyl)phenyl]hydrazine hydrochloride. Recent advancements in flow chemistry and continuous manufacturing have addressed some of these issues, as reported in a 2023 article in Organic Process Research & Development. The study demonstrated a scalable and efficient synthesis route, achieving high yields and purity while minimizing waste generation. These developments are expected to facilitate the broader adoption of this compound in industrial and academic research settings.

In conclusion, [2-fluoro-4-(trifluoromethyl)phenyl]hydrazine hydrochloride (CAS: 1030313-53-1) continues to be a valuable tool in chemical biology and pharmaceutical research. Its unique structural features enable the development of diverse therapeutic agents with improved efficacy and safety profiles. Ongoing research efforts are likely to uncover additional applications, further solidifying its role in drug discovery and development.

• 144851-61-6(2-Amino-3-fluorobenzotrifluoride)
• 1868-85-5(2,3,5,6-Tetrafluoro-4-(trifluoromethyl)phenylhydrazine)
• 5052-05-1((2-Fluoro-4-methylphenyl)hydrazine hydrochloride)
• 927901-61-9((2-Fluoro-3-methyl-6-(trifluoromethyl)phenyl)hydrazine)
• 912761-86-5(2-fluoro-4-(trifluoromethyl)phenylhydrazine)
• 502496-21-1((4-Fluoro-2-(trifluoromethyl)phenyl)hydrazine hydrochloride)
• 1093059-58-5(2-fluoro-5-(trifluoromethyl)phenylhydrazine)
• 69409-98-9(2-Fluoro-4-(trifluoromethyl)aniline)
• 754973-91-6(4-Fluoro-2-(trifluoromethyl)phenylhydrazine)
• 69403-12-9(2-Fluoro-4-(trifluoromethyl)aniline)